Alexion to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology
September 25 2018 - 4:30PM
Business Wire
Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that
management will present at the Leerink Partners Roundtable Series:
Rare Disease & Oncology in New York, NY on Tuesday, October 2,
2018 at 10 a.m., EDT.
An audio webcast of the presentation will be available live. You
can access the webcast at: http://ir.alexion.com. An archived
version of the remarks will also be available through the Company’s
website for a limited time following the conference.
[ALXN-G]
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180925006098/en/
Alexion PharmaceuticalsInvestorsSusan Altschuller, Ph.D.Vice
President, Investor Relations(475) 230-3534
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Apr 2023 to Apr 2024
